HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Racial Differences in Survival of Elderly Adults with Chronic Myeloid Leukemia Before and After the Introduction of Imatinib in the United States.

AuthorsBinay Kumar Shah, Dipesh Uprety
JournalJournal of the American Geriatrics Society (J Am Geriatr Soc) Vol. 64 Issue 4 Pg. 887-9 (Apr 2016) ISSN: 1532-5415 [Electronic] United States
PMID27100589 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents
  • Imatinib Mesylate
Topics
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Humans
  • Imatinib Mesylate (therapeutic use)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, ethnology, mortality)
  • Male
  • SEER Program
  • Survival Rate
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: